| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1091167088 |
| P356 | DOI | 10.1186/S12864-017-3997-7 |
| P932 | PMC publication ID | 5553681 |
| P698 | PubMed publication ID | 28800721 |
| P2093 | author name string | Raj K Puri | |
| Abhinav Kumar | |||
| Ian H Bellayr | |||
| P2860 | cites work | Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs | Q24537328 |
| MicroRNA genes are transcribed by RNA polymerase II | Q24562649 | ||
| Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs | Q24651962 | ||
| Circulating microRNAs as stable blood-based markers for cancer detection | Q24652098 | ||
| Processing of intronic microRNAs | Q24677011 | ||
| MicroRNA biogenesis and their functions in regulating stem cell potency and differentiation | Q26766383 | ||
| Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement | Q27861120 | ||
| microRNAs: tiny regulators with great potential | Q28214699 | ||
| Control of developmental timing in animals | Q28215106 | ||
| miRBase: annotating high confidence microRNAs using deep sequencing data | Q28660701 | ||
| Repression of protein synthesis by miRNAs: how many mechanisms? | Q29620361 | ||
| Microarray data analysis: from disarray to consolidation and consensus | Q33230059 | ||
| Aging of mesenchymal stem cell in vitro. | Q33236089 | ||
| Replicative senescence of mesenchymal stem cells: a continuous and organized process | Q33336408 | ||
| Potential Urinary miRNA Biomarker Candidates for the Accurate Detection of Prostate Cancer among Benign Prostatic Hyperplasia Patients | Q37596754 | ||
| Mesenchymal stem cells: a new trend for cell therapy | Q37729093 | ||
| The role of microRNAs in self-renewal and differentiation of mesenchymal stem cells | Q37834736 | ||
| Clinical applications of mesenchymal stem cells | Q38122364 | ||
| Concise review: MicroRNA function in multipotent mesenchymal stromal cells. | Q38214780 | ||
| MicroRNA expression during osteogenic differentiation of human multipotent mesenchymal stromal cells from bone marrow | Q38336568 | ||
| Tissue engineering and microRNAs: future perspectives in regenerative medicine | Q38552026 | ||
| Expansion induced microRNA changes in bone marrow mesenchymal stromal cells reveals interplay between immune regulation and cell cycle. | Q38794705 | ||
| miR-146a and miR-638 in BRCA1-deficient triple negative breast cancer tumors, as potential biomarkers for improved overall survival | Q38797427 | ||
| MiR-572 prompted cell proliferation of human ovarian cancer cells by suppressing PPP2R2C expression | Q38800774 | ||
| MiR-29a is an enhancer of mineral deposition in bone-derived systems. | Q38954675 | ||
| miR-638 suppresses cell proliferation in gastric cancer by targeting Sp2. | Q39016114 | ||
| Garcinol sensitizes human pancreatic adenocarcinoma cells to gemcitabine in association with microRNA signatures | Q39215505 | ||
| Quantitative approaches to detect donor and passage differences in adipogenic potential and clonogenicity in human bone marrow-derived mesenchymal stem cells. | Q39352677 | ||
| Identification of Predictive Gene Markers for Multipotent Stromal Cell Proliferation | Q39871060 | ||
| High Content Imaging of Early Morphological Signatures Predicts Long Term Mineralization Capacity of Human Mesenchymal Stem Cells upon Osteogenic Induction | Q40006233 | ||
| The proteomic dataset for bone marrow derived human mesenchymal stromal cells: Effect of in vitro passaging | Q40173108 | ||
| miR-429 represses cell proliferation and induces apoptosis in HBV-related HCC. | Q41702566 | ||
| A functional BRCA1 coding sequence genetic variant contributes to risk of esophageal squamous cell carcinoma. | Q42602791 | ||
| Impact of normalization on miRNA microarray expression profiling | Q43161221 | ||
| Global proteomic signature of undifferentiated human bone marrow stromal cells: evidence for donor-to-donor proteome heterogeneity | Q43921522 | ||
| A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma | Q44460060 | ||
| Comparison of normalization methods with microRNA microarray | Q46179676 | ||
| Knockdown of miR-210 decreases hypoxic glioma stem cells stemness and radioresistance | Q46879426 | ||
| Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study | Q48296508 | ||
| Chromatin Changes at the PPAR-γ2 Promoter During Bone Marrow-Derived Multipotent Stromal Cell Culture Correlate With Loss of Gene Activation Potential. | Q50603538 | ||
| MiR-132, miR-15a and miR-16 synergistically inhibit pituitary tumor cell proliferation, invasion and migration by targeting Sox5 | Q85753535 | ||
| System-wide survey of proteomic responses of human bone marrow stromal cells (hBMSCs) to in vitro cultivation | Q86602136 | ||
| MicroRNA biomarkers in whole blood for detection of pancreatic cancer | Q87140824 | ||
| Processing of Agilent microRNA array data | Q33537410 | ||
| Loss of miR-638 in vitro promotes cell invasion and a mesenchymal-like transition by influencing SOX2 expression in colorectal carcinoma cells | Q33690671 | ||
| Cytomegalovirus microRNAs facilitate persistent virus infection in salivary glands | Q33728506 | ||
| Gene markers of cellular aging in human multipotent stromal cells in culture | Q33746617 | ||
| Chromosomal stability of mesenchymal stromal cells during in vitro culture | Q33917128 | ||
| Technical variability is greater than biological variability in a microarray experiment but both are outweighed by changes induced by stimulation | Q33927399 | ||
| MicroRNAs: key regulators of stem cells | Q33987468 | ||
| Viral miRNAs in plasma and urine divulge JC polyomavirus infection | Q34208184 | ||
| Expression of microRNAs in basal cell carcinoma. | Q34271420 | ||
| Regulation of microRNAs by natural agents: an emerging field in chemoprevention and chemotherapy research | Q34283589 | ||
| Mesenchymal stem cells for the treatment of neurodegenerative disease. | Q34473474 | ||
| Improved proteomic profiling of the cell surface of culture-expanded human bone marrow multipotent stromal cells. | Q34478650 | ||
| Characterization of paraquat-induced miRNA profiling response in hNPCs undergoing proliferation | Q34486835 | ||
| Salivary microRNAs as promising biomarkers for detection of esophageal cancer | Q34656109 | ||
| miR-638 mediated regulation of BRCA1 affects DNA repair and sensitivity to UV and cisplatin in triple-negative breast cancer | Q35000253 | ||
| MicroRNA-638 inhibits cell proliferation, invasion and regulates cell cycle by targeting tetraspanin 1 in human colorectal carcinoma. | Q35068001 | ||
| miR-638 regulates differentiation and proliferation in leukemic cells by targeting cyclin-dependent kinase 2 | Q35121352 | ||
| Different microRNA expression levels in gastric cancer depending on Helicobacter pylori infection | Q35151777 | ||
| MicroRNA delivery for regenerative medicine | Q35863950 | ||
| MicroRNA-638 inhibits cell proliferation by targeting phospholipase D1 in human gastric carcinoma | Q35956839 | ||
| Upregulation of miR-572 transcriptionally suppresses SOCS1 and p21 and contributes to human ovarian cancer progression | Q36020966 | ||
| Automated microscopy as a quantitative method to measure differences in adipogenic differentiation in preparations of human mesenchymal stromal cells | Q36051445 | ||
| Bafilomycin A1 inhibits the growth and metastatic potential of the BEL-7402 liver cancer and HO-8910 ovarian cancer cell lines and induces alterations in their microRNA expression | Q36336343 | ||
| MicroRNAs silence gene expression by repressing protein expression and/or by promoting mRNA decay. | Q36768214 | ||
| MicroRNA gets down to business | Q36844136 | ||
| The effect of extended first passage culture on the proliferation and differentiation of human marrow-derived mesenchymal stem cells. | Q36861537 | ||
| MicroRNA-638 is highly expressed in human vascular smooth muscle cells and inhibits PDGF-BB-induced cell proliferation and migration through targeting orphan nuclear receptor NOR1 | Q36943405 | ||
| Identity, proliferation capacity, genomic stability and novel senescence markers of mesenchymal stem cells isolated from low volume of human bone marrow. | Q36998092 | ||
| Intra-subject variability in human bone marrow stromal cell (BMSC) replicative senescence: molecular changes associated with BMSC senescence | Q37281919 | ||
| Downregulation of miRNA-638 promotes angiogenesis and growth of hepatocellular carcinoma by targeting VEGF. | Q37327584 | ||
| Assessment of immunosuppressive activity of human mesenchymal stem cells using murine antigen specific CD4 and CD8 T cells in vitro | Q37372319 | ||
| Prognostic value of 5-microRNA based signature in T2-T3N0 colon cancer | Q37416261 | ||
| A panel of five serum miRNAs as a potential diagnostic tool for early-stage renal cell carcinoma | Q37499747 | ||
| Regulation of stem cell populations by microRNAs | Q37513688 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA expression | Q60681249 |
| P304 | page(s) | 605 | |
| P577 | publication date | 2017-08-11 | |
| P1433 | published in | BMC Genomics | Q15765854 |
| P1476 | title | MicroRNA expression in bone marrow-derived human multipotent Stromal cells | |
| P478 | volume | 18 |
| Q64998142 | Epigenetic Crosstalk between the Tumor Microenvironment and Ovarian Cancer Cells: A Therapeutic Road Less Traveled. |
| Q64084376 | Hypoxia-Regulated miRNAs in Human Mesenchymal Stem Cells: Exploring the Regulatory Effects in Ischemic Disorders |
| Q57460455 | MicroRNAs in the Migration of Mesenchymal Stem Cells |
| Q92523675 | Mircrining the injured heart with stem cell-derived exosomes: an emerging strategy of cell-free therapy |
Search more.